BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 22406547)

  • 1. NgR1 and NgR3 are receptors for chondroitin sulfate proteoglycans.
    Dickendesher TL; Baldwin KT; Mironova YA; Koriyama Y; Raiker SJ; Askew KL; Wood A; Geoffroy CG; Zheng B; Liepmann CD; Katagiri Y; Benowitz LI; Geller HM; Giger RJ
    Nat Neurosci; 2012 Mar; 15(5):703-12. PubMed ID: 22406547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nogo receptor 3, a paralog of Nogo-66 receptor 1 (NgR1), may function as a NgR1 co-receptor for Nogo-66.
    Zhang L; Kuang X; Zhang J
    J Genet Genomics; 2011 Nov; 38(11):515-23. PubMed ID: 22133682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular basis of the interactions of the Nogo-66 receptor and its homolog NgR2 with myelin-associated glycoprotein: development of NgROMNI-Fc, a novel antagonist of CNS myelin inhibition.
    Robak LA; Venkatesh K; Lee H; Raiker SJ; Duan Y; Lee-Osbourne J; Hofer T; Mage RG; Rader C; Giger RJ
    J Neurosci; 2009 May; 29(18):5768-83. PubMed ID: 19420245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Nogo-66 receptor homolog NgR2 is a sialic acid-dependent receptor selective for myelin-associated glycoprotein.
    Venkatesh K; Chivatakarn O; Lee H; Joshi PS; Kantor DB; Newman BA; Mage R; Rader C; Giger RJ
    J Neurosci; 2005 Jan; 25(4):808-22. PubMed ID: 15673660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of myelin ligand complexes with neuronal Nogo-66 receptor family members.
    Laurén J; Hu F; Chin J; Liao J; Airaksinen MS; Strittmatter SM
    J Biol Chem; 2007 Feb; 282(8):5715-25. PubMed ID: 17189258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of Nogo-66 receptor 1 function in vivo after spinal cord injury.
    Tong J; Ren Y; Wang X; Dimopoulos VG; Kesler HN; Liu W; He X; Nedergaard M; Huang JH
    Neurosurgery; 2014 Jul; 75(1):51-60. PubMed ID: 24594926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MAG and OMgp synergize with Nogo-A to restrict axonal growth and neurological recovery after spinal cord trauma.
    Cafferty WB; Duffy P; Huebner E; Strittmatter SM
    J Neurosci; 2010 May; 30(20):6825-37. PubMed ID: 20484625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nogo-receptors NgR1 and NgR2 do not mediate regulation of CD4 T helper responses and CNS repair in experimental autoimmune encephalomyelitis.
    Steinbach K; McDonald CL; Reindl M; Schweigreiter R; Bandtlow C; Martin R
    PLoS One; 2011; 6(11):e26341. PubMed ID: 22096481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nogo receptor is involved in the adhesion of dendritic cells to myelin.
    McDonald CL; Steinbach K; Kern F; Schweigreiter R; Martin R; Bandtlow CE; Reindl M
    J Neuroinflammation; 2011 Sep; 8():113. PubMed ID: 21906273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spatio-temporal expression pattern of receptors for myelin-associated inhibitors in the developing rat olfactory system.
    Richard M; Sacquet J; Jourdan F; Pellier-Monnin V
    Brain Res; 2009 Feb; 1252():52-65. PubMed ID: 19063867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of chondroitin sulfate proteoglycans-induced axonal growth inhibition by LOTUS.
    Kurihara Y; Saito Y; Takei K
    Neuroscience; 2017 Jul; 356():265-274. PubMed ID: 28571719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scar-mediated inhibition and CSPG receptors in the CNS.
    Sharma K; Selzer ME; Li S
    Exp Neurol; 2012 Oct; 237(2):370-8. PubMed ID: 22836147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LOTUS suppresses axon growth inhibition by blocking interaction between Nogo receptor-1 and all four types of its ligand.
    Kurihara Y; Iketani M; Ito H; Nishiyama K; Sakakibara Y; Goshima Y; Takei K
    Mol Cell Neurosci; 2014 Jul; 61():211-8. PubMed ID: 25034269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of Nogo receptor 1 in microglia during development and following traumatic brain injury.
    Liu G; Ni J; Mao L; Yan M; Pang T; Liao H
    Brain Res; 2015 Nov; 1627():41-51. PubMed ID: 26367446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Axonal regeneration induced by blockade of glial inhibitors coupled with activation of intrinsic neuronal growth pathways.
    Wang X; Hasan O; Arzeno A; Benowitz LI; Cafferty WB; Strittmatter SM
    Exp Neurol; 2012 Sep; 237(1):55-69. PubMed ID: 22728374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TAJ/TROY, an orphan TNF receptor family member, binds Nogo-66 receptor 1 and regulates axonal regeneration.
    Shao Z; Browning JL; Lee X; Scott ML; Shulga-Morskaya S; Allaire N; Thill G; Levesque M; Sah D; McCoy JM; Murray B; Jung V; Pepinsky RB; Mi S
    Neuron; 2005 Feb; 45(3):353-9. PubMed ID: 15694322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oligodendrocyte-myelin glycoprotein and Nogo negatively regulate activity-dependent synaptic plasticity.
    Raiker SJ; Lee H; Baldwin KT; Duan Y; Shrager P; Giger RJ
    J Neurosci; 2010 Sep; 30(37):12432-45. PubMed ID: 20844138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex.
    Mi S; Lee X; Shao Z; Thill G; Ji B; Relton J; Levesque M; Allaire N; Perrin S; Sands B; Crowell T; Cate RL; McCoy JM; Pepinsky RB
    Nat Neurosci; 2004 Mar; 7(3):221-8. PubMed ID: 14966521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The nogo receptor family restricts synapse number in the developing hippocampus.
    Wills ZP; Mandel-Brehm C; Mardinly AR; McCord AE; Giger RJ; Greenberg ME
    Neuron; 2012 Feb; 73(3):466-81. PubMed ID: 22325200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered expression of myelin-associated inhibitors and their receptors after traumatic brain injury in the mouse.
    Israelsson C; Flygt J; Åstrand E; Kiwanuka O; Bengtsson H; Marklund N
    Restor Neurol Neurosci; 2014; 32(5):717-31. PubMed ID: 25079982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.